SITC is pleased to announce the publication of our newest guideline, " Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer. " Clinicians will find this guideline an invaluable resource to assist in navigating the challenging issues that sometimes arise during the treatment of gastrointestinal cancer, including treatment selection based on histology and biomarker status, toxicity management, and quality of life and patient education. This guideline covers immunotherapy for the treatment of esophageal, GE junction, gastric, duodenal and distal small bowel, pancreaticobiliary, colorectal, and anal cancer. The manuscript, the latest in the ongoing series of SITC Cancer Immunotherapy Guidelines, is available now in the Journal for ImmunoTherapy of Cancer ( JITC ), the society’s open access, peer-reviewed online journal and a mobile version with interactive tools will be available in the SITC CPG Mobile App soon
Beginning tomorrow, June 1, SITC will join our colleagues at the Cancer Research Institute to celebrate Cancer Immunotherapy Awareness Month™
The following articles have been recommended for further reading in the field of cancer immunotherapy by JITC's Oncolytic and Local Immunotherapy Section Editor, Howard L
“T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis” by Daria Briukhovetska et al Immunity (2023) IL-22-producing helper (T h ) cells are associated with poor prognosis in breast and lung cancer. Daria Briukhovetska et al identified a pathway by which IL-22 binding to its receptor on tumor cells suppresses natural killer (NK) cell activity to promote breast and lung cancer metastasis. Compared to wildtype, mice lacking IL-22 expression experienced lower metastatic spread to the lungs when implanted or intravenously injected with lung or breast cancer cell lines
The Society for Immunotherapy of Cancer (SITC) hosted the 2021 SITC Cancer Immunotherapy Winter School, a comprehensive cancer immunotherapy education program, virtually on February 22-24, 2021. Available here are the presentation slides and video from Monday, February 22, 2021. Program Organizers Christian Capitini, MD – University of Wisconsin-Madison Leisha A. Emens, MD, PhD – UPMC Hillman Cancer Center Daniel Powell, PhD – University of Pennsylvania Program Summary Taught by leading experts in the field, this program provided a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis and considerations for combination therapies. The program was tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings as well as those new to the field
22 attachments
See matching library entry files - Meeting: 2021 SITC Cancer Immun...
The Society for Immunotherapy of Cancer (SITC) hosted the Tumor Immune Microenvironment: A Holistic Approach Workshop both in San Diego, CA and virtually on April 21–22, 2022 . Available here are the presentation slides and video from Friday, April 22, 2022. Program Organizers Christian M. Capitini, MD – University of Wisconsin-Madison Sandra Demaria, MD – Weill Cornell Medicine Stefani Spranger, PhD – Koch Institute for Integrative Cancer Research at MIT Program Summary Immunotherapeutic approaches are not equally effective across cancer types because not all tumor types are the same
19 attachments
See matching library entry files - Meeting: Tumor Immune Microenvironment: A Holist...
SITC has grown with the field – eclipsing 2,400 members in 2018 – and remains at the forefront of scientific and clinical advances in cancer immunotherapy. Beginning tomorrow, June 1, SITC will join our colleagues at the Cancer Research Institute to celebrate Cancer Immunotherapy Awareness Month™
The Primer session is jointly provided by the Society for Immunotherapy of Cancer (SITC) and the Postgraduate Institute for Medicine (PIM), in collaboration with Weill Cornell Medicine and Gustave Roussy. The Primer Session on Radiation Therapy as a Combinatorial Partner for Immunotherapy will be held on September 22, 2022 and is part of the 6th International Conference on Immunotherapy Radiotherapy Combinations from September 22 - 24, 2022
09-22-2022 | 10:00 - 12:30 ET New York NY
Presented by the Arab Medical Association Against Cancer and the Algerian Society of Medical Oncology in collaboration with the Society for Immunotherapy of Cancer The 17th Pan Arab Cancer Congress (PACC), to be held on April 20-22, 2017, will explore the experiences and case studies of cancer management in the 22 Arabic countries, compare medical practices to local and global guidelines and offer networking opportunities for oncology clinicians and others involved in the cancer field. New this year, SITC is organizing an immunotherapy session to provide oncology practitioners with an understanding of the mechanisms of action of immunotherapy agents, discuss current clinical applications for melanoma and lung cancers, and introduce current and emerging treatment methods for additional disease states
04-21-2017 Algiers
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us